Home
|
Pharmacovigilance
|
Contacts
|
SpeakUp&BeHeard
|
Chiesi Group
ES
EN
Welcome to Chiesi
Spain
Enter at least 3 characters
About Chiesi
Executive Commitee
We are B Corp
Mission and values
Therapeutic Areas
Respiratory
Neonatology
Rare Disease
Transplantation
Cardiovascular
Consumer Healthcare
R&D
R&D in Spain
Pipeline
Products
Therapeutic areas
Consumer Health Care
Our People
Professional Opportunities
Corporate Social Responsibility
Ethic
Supply Chain Sustainability
We act - Sustainability Manifesto
Transparency
SpeakUp&BeHeard
Chiesi foundation
Media Area
HOME
>
Respiratory
>
Quinsair 240 mg
BRAMITOB
BRONCHITOL 40 MG
BRONCORAL NEO
CEMIDÓN 150 B6
CEMIDÓN 300 B6
CEMIDÓN 50 B6
CEMIDÓN INTRAVENOSO
FOSTER 100/6 microgramos/pulsación
FOSTER NEXTHALER 100/6 microgramos/inhalación
FOSTER NEXTHALER 200/6 microgramos/inhalación
FOSTER 200/6 microgramos/pulsación
KLEDAX cápsulas
Quinsair 240 mg
TRIMBOW
-
-
Quinsair 240 mg
-
Back
Prospecto
Ficha técnica
CHIESI ON THE WEB
Alemania
Chiesi GmbH
Austria
Chiesi Pharmaceuticals GmbH
Bélgica
Chiesi sa
Brasil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Eslovaquia
Chiesi Slovakia s.r.o
Eslovenia
Chiesi Slovenija, d.o.o
España
Chiesi España S.A.
Estados Unidos
Chiesi Usa Inc.
Francia
Chiesi S.A.
Grecia
Chiesi Hellas Pharmaceuticals S.A.
Hungría
Chiesi Hungary Kft.
Italia
Divisione Farmaceutica Italia
México
Chiesi México S.A. de C.V.
Países Bajos
Chiesi Pharmaceuticals B.V.
Pakistán
Chiesi Pharmaceuticals (Pvt) Limited
Polonia
Chiesi Polonia
Reino Unido
Chiesi Ltd
República Checa
Chiesi CZ s.r.o.
Rumania
Chiesi România S.r.l.
Rusia
Chiesi Pharmaceuticals LLC
Suecia
Chiesi Pharma AB
Turquía
Chiesi İlaçTicaret Limited Sirketi A.Ş.
Prospecto